Concurrent versus sequential administration of CMF chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer

National Institutes of Health Consensus Development Panel: Consensus statement: Treatment of early-stage breast cancer. J Natl Cancer Inst Monogr, 11: 1–5, 1992.

Fisher B. , Anderson S. , Bryant J. , Margolese R.G. , Deutsch M. , Fisher E.R. , Jeong J.H. , Wolmark N. : Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med, 347: 1233–1241, 2002.

Fyles A.W. , McCready D.R. , Manchul L.A. , Trudeau M.E. , Merante P. , Pintilie M. , Weir L.M. , Olivotto I.A. : Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med, 351: 963–970, 2004.

Early Breast Cancer Trialists' Collaborative Group: Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet, 352: 930–942, 1998.

Buchholz T.A. , Austin-Seymour M.M. , Moe R.E. , Ellis G.K. , Livingston R.B. , Pelton J.G. , Griffin T.W. : Effect of delay in radiation in the combined treatment of breast cancer. Int J Radiat Oncol Biol Phys, 26: 23–35, 1993.

Hartsell W.F. , Recine D.C. , Griem K.L. , Murthy A.K. : Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence. Cancer, 76: 2497–2503, 1995.

Recht A. , Come S.E. , Gelman R.S. , Goldstein M. , Tishler S. , Gore S.M. , Abner A.L. , Vicini F.A. , Silver B. , Connolly J.L. : Integration of conservative surgery, radiotherapy and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome. J Clin Oncol, 9: 1662–1667, 1991.

Bellon J.R. , Come S.E. , Gelman R.S. , Henderson I.C. , Shulman L.N. , Silver B.J. , Harris J.R. , Recht A. : Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol, 23: 1934–1940, 2005.

Isaac N. , Panzarella T. , Lau A. , Mayers C. , Kirkbride P. , Tannock I.F. , Vallis K.A. : Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen. Cancer, 95: 696–703, 2002.

Faul C. , Brufsky A. , Gerszten K. , Flickinger J. , Kunschner A. , Jacob H. , Vogel V. : Concurrent sequencing of full-dose CMF chemotherapy and radiation therapy in early breast cancer has no effect on treatment delivery. Eur J Cancer, 39: 763–768, 2003.

American Joint Committee on Cancer: AJCC Cancer Staging Manual, 6th edn, Springer-Verlag, New York, 2002.

Cox J.D. , Stetz J. , Pajak T.F. : Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys, 31: 1341–1346, 1995.

Danoff B.F. , Goodman R.L. , Glick J.H. , Heller D.G. , Pajak T.F. : The effect of adjuvant chemotherapy on cosmesis and complications in patients with breast cancer treated by definitive irradiation. Int J Radiat Oncol Biol Phys, 9: 1625–1630, 1983.

Kaplan E.L. , Meier P.I. : A nonparametric estimation from incomplete observations. J Am Statics Assoc, 53: 457–481, 1958.

Huang J. , Barbera L. , Brouwers M. , Browman G. , Mackillop W.J. : Dose delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol, 21: 555–563, 2003.

Valagussa P. , Zambetti M. , Biasi S. , Moliterni A. , Zucali R. , Bonadonna G. : Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancer. Ann Oncol, 5: 209–216, 1994.

Bellon J.R. , Lindsley K.L. , Ellis G.K. , Gralow J.R. , Livingston R.B. , Seymour M.M. : Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer. Int J Radiat Oncol Biol Phys, 48: 393–397, 2000.

Hanna Y.M. , Baglan K.L. , Stromberg J.S. , Vicini F.A. , Decker D.A. : Acute and subacute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer therapy. Breast J, 8: 149–153, 2002.

Burstein H.J. , Bellon J.R. , Galper S. , Lu H.M. , Kuter I. , Taghian A.G. , Wong J. , Gelman R. , Bunnell C.A. , Parker L.M. , Garber J.E. , Winer E.P. , Harris J.R. , Powell S.N. : Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for stage II or III breast cancer. Int J Radiat Oncol Biol Phys, 64: 496–504, 2006.

Giordano S.H. , Kuo Y.F. , Freeman J.L. , Buchholz T.A. , Hortobagyi G.N. , Goodwin J.S. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst, 97: 419–424, 2005.

Toledano A. , Garaud P. , Serin D. , Fourquet A. , Bosset J.F. , Breteau N. , Body G. , Azria D. , Le Floch O. , Calais G. : Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study. Int J Radiat Oncol Biol Phys, 65: 324–332, 2006.

Toledano A.H. , Bollet M.A. , Fourquet A. , Azria D. , Gliogorov J. , Garaud P. , Serin D. , Bosset J.F. , Miny-Buffet J. , Favre A. , LeFoch O. , Calais G. : Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast-conserving surgery? Results of the ARCOSEIN multicenter, phase III study: patients' and doctors' view. Int J Radiat Oncol Biol Phys, 68: 66–72, 2007.

Arcangeli G. , Pinnarò P. , Rambone R. , Giannarelli D. , Benassi M. : A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer. Int J Radiat Oncol Biol Phys, 64: 161–167, 2006.

Rouëssé J. , de la Lande B. , Bertheault-Cvitkovic F. , Serin D. , Graïc Y. , Combe M. , Leduc B. , Lucas V. , Demange L. , Nguyen T.D. , Castèra D. , Krzisch C. , Villet R. , Mouret-Fourme E. , Garbay J.R. , Noguès C. : A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: Final results. Int J Radiat Oncol Biol Phys, 64: 1072–1080, 2006.

Toledano A. , Azria D. , Garaud P. , Fourquet A. , Serin D. , Bosset J.F. , Miny-Buffet J. , Favre A. , Le Floch O. , Calais G. : Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial. J Clin Oncol, 25: 405–410, 2007.

Haffty B.G. , Kim J.H. , Yang Q. , Higgins S.A. : Concurrent chemoradiation in the conservative management of breast cancer. Int J Radiat Oncol Biol Phys, 66: 1306–1312, 2006.

Fisher B. , Anderson S. , Tan-Chiu E. , Wolmark N. , Wickerham D.L. , Fisher E.R. , Dimitrov N.V. , Atkins J.N. , Abramson N. , Merajver S. , Romond E.H. , Kardinal C.G. , Shibata H.R. , Margolese R.G. , Farrar W.B. : Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23. J Clin Oncol, 19: 931–942, 2001.

Fisher B. , Brown A.M. , Dimitrov N.V. , Poisson R. , Redmond C. , Margolese R.G. , Bowman D. , Wolmark N. , Wickerham D.L. , Kardinal C.G. : Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15. J Clin Oncol, 8: 1483–1496, 1990.

NCCN Practice guidelines in oncology V.1.2010: Breast cancer. Available at http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf (accessed December 3, 2009).

Nixon A.J. , Schnitt S.J. , Gelman R. , Gage I. , Bornstein B. , Hetelekidis S. , Recht A. , Silver B. , Harris J.R. , Connolly J.L. : Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy. Cancer, 78: 1426–1431, 1996.

Vrieling C. , Collette L. , Fourquet A. , Hoogenraad W.J. , Horiot J.C. , Jager J.J. , Bing Oei S. , Peterse H.L. , Pierart M. , Poortmans P.M. , Struikmans H. , Van den Bogaert W. , Bartelink H. : Can patient-, treatment-, and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer, 39: 932–944, 2003.